sj-tif-2-tct-10.1177_15330338241248573 - Supplemental material for Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer

Supplemental material, sj-tif-2-tct-10.1177_15330338241248573 for Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer by Sujuan Peng, Hongxiang Huang, Jinhong Chen, Xinjing Ding, Xie Zhu, Yangyang Liu, Li Chen, and Zhihui Lu in Technology in Cancer Research & Treatment</p

sj-tif-1-tct-10.1177_15330338241248573 - Supplemental material for Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer

Supplemental material, sj-tif-1-tct-10.1177_15330338241248573 for Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer by Sujuan Peng, Hongxiang Huang, Jinhong Chen, Xinjing Ding, Xie Zhu, Yangyang Liu, Li Chen, and Zhihui Lu in Technology in Cancer Research & Treatment</p

Combining Metabolic Engineering and Lipid Droplet Storage Engineering for Improved α‑Bisabolene Production in <i>Yarrowia Lipolytica</i>

Bisabolene is a bioactive sesquiterpene with a wide range of applications in food, cosmetics, medicine, and aviation fuels. Microbial production offers a green, efficient, and sustainable alternative. In this study, we focused on improving the titers of α-bisabolene in Yarrowia lipolytica by applying two strategies, (i) optimizing the metabolic flux of α-bisabolene biosynthetic pathway and (ii) sequestering α-bisabolene in lipid droplet, thus alleviating its inherent toxicity to host cells. We showed that overexpression of DGA1 and OLE1 to increase lipid content and unsaturated fatty acid levels was essential for boosting the α-bisabolene synthesis when supplemented with auxiliary carbon sources. The final engineered strain Po1gαB10 produced 1954.3 mg/L α-bisabolene from the waste cooking oil under shake flask fermentation, which was 96-fold higher than the control strain Po1gαB0. At the time of writing, our study represents the highest reported α-bisabolene titer in the engineered Y. lipolytica cell factory. This work describes novel strategies to improve the bioproduction of α-bisabolene that potentially may be applicable for other high-value terpene products

Enhanced limonene production by metabolically engineered Yarrowia lipolytica from cheap carbon sources

Limonene is a valuable monoterpene widely used in the food and pharmaceutical industries. Previously, we successfully engineered Yarrowia lipolytica to produce limonenes. In this study, we focused on improving the titers of limonenes in Y. lipolytica by optimizing the metabolic flux of the limonene biosynthetic pathway and the medium composition. First, we adopted a combinatorial gene (over)expression strategy to improve the production of limonenes, obtaining the highest titer production strains. Subsequently, the medium composition and fed-batch fermentation were optimized to improve limonene biosynthesis, and it was confirmed that waste cooking oil (WCO) is the superior substrate to produce limonenes in Y. lipolytica. Under optimal fermentation conditions, the titers of D-limonene and L-limonene were improved to 91.24 mg/L and 83.06 mg/L from WCO. These findings provide valuable insights into the engineering of Y. lipolytica for a higher-level production of limonene and its utilization in converting WCO into other industrial products